Lv2
160 积分 2023-10-07 加入
Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia
12天前
已完结
Rumex japonicus Houtt.: A phytochemical, pharmacological, and pharmacokinetic review
2个月前
已完结
The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?
2个月前
已完结
Management of Immune Thrombotic Thrombocytopenic Purpura without Therapeutic Plasma Exchange
2个月前
已完结
Management of Immune Thrombotic Thrombocytopenic Purpura without Therapeutic Plasma Exchange
2个月前
已关闭
Management of Immune Thrombotic Thrombocytopenic Purpura without Therapeutic Plasma Exchange
2个月前
已关闭
ADAR1 Is a Vulnerability in TP53-Mutant Acute Myeloid Leukemia
2个月前
已完结
ADAR1 Is a Vulnerability in TP53-Mutant Acute Myeloid Leukemia
2个月前
已关闭
CALCRL induces resistance to daunorubicin in acute myeloid leukemia cells through upregulation of XRCC5/TYK2/JAK1 pathway
4个月前
已完结
Assessing the Mechanism of Cytarabine-Induced Killing in Acute Leukemia
4个月前
已关闭
皖公网安备34019202002308
